Xeris Biopharma Holdings, Inc.

Pharmaceutical Preparations | SIC: 2834
Phone: 844-445-5704
CIK: 0001867096
EIN: 871082097
State Location: IL
Tickers:
  • Nasdaq:XERS

Form: 4

Filing Date: 01 Apr 2026
Report Date: 30 Mar 2026
Accepted: 01 Apr 2026 03:54 p.m.
Accession Number: 0001916987-26-000002
Act: None
File Number: None
Film Number: None

Documents

Primary Document: FORM 4
Accepted: 01 Apr 2026 03:54 p.m.